npj Breast Cancer

New collections open to submissions

Featured

Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy

Jens Huober
Marion van Mackelenbergh
Michael Untch
ArticleOpen Access07 Apr 2023
An emerging generation of endocrine therapies in breast cancer: a clinical perspective

Rima Patel
Paula Klein
Joseph A. Sparano
Review ArticleOpen Access05 Apr 2023

Announcements

npj Breast Cancer Journal Metrics

npj Breast Cancer has a 2-year impact factor of 7.519 (2021), article downloads of 504,813 (2021) and 6 days from submission to the first editorial decision (2021).
Call for papers: AI in precision oncology

Submit to our new collection focused on AI in precision oncology, deadline: 19 October 2023.

Open for submissions
Call for papers: blood biomarkers in breast cancer

Submit to our new collection focused on blood biomarkers in breast cancer, deadline: 31 January 2024.

Open for submissions
Follow us on Twitter

Keep up to date with the journal and new publications by following us on Twitter. Share your work by tagging @Nature_NPJ and using our hashtag #npjBCancer.

Browse articles

Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer

Stefania Morganti
Heather A. Parsons
Albert Grinshpun
Review ArticleOpen Access24 May 2023
International research to address the challenges of metastatic breast cancer: the AURORA Program (BIG 14-01)

Despite recent advances in breast cancer research, we still know little about the mechanisms that lead to metastatic breast cancer (MBC). However, treatment options for patients have increased based on results of recent randomized clinical trials in this setting. Today we have much hope, yet many questions remain unanswered. Conducting a fully academic and international study such as AURORA is very challenging, yet ever more crucial to advancing knowledge about MBC.

Carmela Caballero
Alexandre Irrthum
Martine Piccart
CommentOpen Access23 May 2023
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2− advanced breast cancer

Anthony D. Elias
Nicole S. Spoelstra
Jennifer K. Richer
ArticleOpen Access20 May 2023
Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer

Yuli Chen
Haojia Li
Anant Madabhushi
ArticleOpen Access17 May 2023
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial

Kristina A. Fanucci
Yalai Bai
Kim R. M. Blenman
ArticleOpen Access13 May 2023
Immune landscape of breast tumors with low and intermediate estrogen receptor expression

Leonie Voorwerk
Joyce Sanders
Marleen Kok
ArticleOpen Access13 May 2023
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

Taru A. Muranen
Anna Morra
Heli Nevanlinna
ArticleOpen Access12 May 2023
Reversion of breast epithelial polarity alterations caused by obesity

Julia Holmes
Mohamed Gaber
Pierre-Alexandre Vidi
ArticleOpen Access09 May 2023
Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer

Ziyan Yang
Jianguo Feng
Wen-Ming Cao
ArticleOpen Access09 May 2023

Trending - Altmetric

Jobs

Associate or Senior Editor, NPJ Series (Health/Life Sciences)

Nature Portfolio is a flagship portfolio of journals, products and services including Nature and the Nature-branded journals, dedicated to serving ...

New York City, New York (US)

Springer Nature Group
Research Assistant III Lab

Seeking a Research Assistant to work with the Kory and Ubellacker labs in the Department of Molecular Metabolism at the Harvard Chan School.

Boston, Massachusetts (US)

Harvard T.H. Chan School of Public Health, Department of Molecular Metabolism
Postdoctoral Associate- RNA Biology, Cancer Biology

Houston, Texas (US)

Baylor College of Medicine (BCM)
Postdoctoral Research Scientist

The Vasan Lab at the Herbert Irving Comprehensive Cancer Center seeks a postdoctoral candidate. Our laboratory specializes in breast cancer, with a...

New York City, New York (US)

Columbia University Irving Medical Center
1-2 Postdoctoral Researchers in Molecular Breast Cancer Epidemiology

1-2 postdoctoral positions are available within the breast cancer research group

Solna (Stad), Stockholm (SE)

Karolinska Institutet (KI)

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

New collections open to submissions

Featured

Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy

An emerging generation of endocrine therapies in breast cancer: a clinical perspective

Announcements

npj Breast Cancer Journal Metrics

Call for papers: AI in precision oncology

Call for papers: blood biomarkers in breast cancer

Follow us on Twitter

Browse articles

Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer

International research to address the challenges of metastatic breast cancer: the AURORA Program (BIG 14-01)

Phase II trial of fulvestrant plus enzalutamide in ER+/HER2− advanced breast cancer

Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer

Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial

Immune landscape of breast tumors with low and intermediate estrogen receptor expression

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

Reversion of breast epithelial polarity alterations caused by obesity

Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer

Trending - Altmetric

Jobs

Associate or Senior Editor, NPJ Series (Health/Life Sciences)

Research Assistant III Lab

Postdoctoral Associate- RNA Biology, Cancer Biology

Postdoctoral Research Scientist

1-2 Postdoctoral Researchers in Molecular Breast Cancer Epidemiology

Search

Quick links

Featured

Announcements

Advertisement

Trending - Altmetric

Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer

Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer

Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer

International research to address the challenges of metastatic breast cancer: the AURORA Program (BIG 14-01)

Search

Quick links